224 related articles for article (PubMed ID: 22424082)
21. Personalized medicine benefits patients in early trials: matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies.
Printz C
Cancer; 2012 Oct; 118(20):4911-2. PubMed ID: 23042614
[No Abstract] [Full Text] [Related]
22. The right roadmap for personalized tests.
Bourzac K
Cancer Discov; 2012 Jun; 2(6):478. PubMed ID: 22684442
[No Abstract] [Full Text] [Related]
23. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
Ludwig WD
Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
[TBL] [Abstract][Full Text] [Related]
24. Impact of tumor sequencing on the use of anticancer drugs.
Thomas F; Desmedt C; Aftimos P; Awada A
Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
[TBL] [Abstract][Full Text] [Related]
25. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
Scolyer RA; Thompson JF
J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
[No Abstract] [Full Text] [Related]
26. From genomic landscapes to personalized cancer management-is there a roadmap?
Swanton C; Caldas C
Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
[TBL] [Abstract][Full Text] [Related]
27. Personalized Approaches to Gastrointestinal Cancers: Importance of Integrating Genomic Information to Guide Therapy.
He J; Ahuja N
Surg Clin North Am; 2015 Oct; 95(5):1081-94. PubMed ID: 26315525
[TBL] [Abstract][Full Text] [Related]
28. What is the future for cancer clinical trials?
Perrone F
Future Oncol; 2015; 11(1):5-7. PubMed ID: 25572779
[No Abstract] [Full Text] [Related]
29. Personalized medicine: the medicine of tomorrow. Foreword.
Tremblay-Servier M
Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
[No Abstract] [Full Text] [Related]
30. Individualized targeted therapy for glioblastoma: fact or fiction?
Weller M; Stupp R; Hegi M; Wick W
Cancer J; 2012; 18(1):40-4. PubMed ID: 22290256
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer management: opportunities and barriers to an individualized approach.
Perez EA
Oncologist; 2011; 16 Suppl 1():20-2. PubMed ID: 21278437
[TBL] [Abstract][Full Text] [Related]
32. [Personalized medicine and molecular targets of drugs].
Nishiyama M
Nihon Rinsho; 2010 Oct; 68(10):1917-22. PubMed ID: 20954340
[TBL] [Abstract][Full Text] [Related]
33. Exploiting combinatorial patterns in cancer genomic data for personalized therapy and new target discovery.
Schubert M; Iorio F
Pharmacogenomics; 2014 Dec; 15(16):1943-6. PubMed ID: 25521353
[No Abstract] [Full Text] [Related]
34. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
Vaiopoulou A; Gazouli M; Karikas GA
J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
[TBL] [Abstract][Full Text] [Related]
35. Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.
Higuchi K; Tanabe S; Azuma M; Sasaki T; Ishido K; Koizumi W
Pathobiology; 2011; 78(6):334-42. PubMed ID: 22104205
[TBL] [Abstract][Full Text] [Related]
36. The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.
Cloonan N; Waddell N; Grimmond SM
IDrugs; 2010 Nov; 13(11):778-81. PubMed ID: 21046525
[TBL] [Abstract][Full Text] [Related]
37. Special report: multiple molecular testing of cancers to identify targeted therapies.
BlueCross BlueShield Association
Technol Eval Cent Assess Program Exec Summ; 2013 Jun; 28(1):1-2. PubMed ID: 23865106
[No Abstract] [Full Text] [Related]
38. Translating basic research in cancer patient care.
Maugeri-Saccà M; De Maria R
Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342
[TBL] [Abstract][Full Text] [Related]
39. Era of personalized medicine may herald end of soaring cancer costs.
Keogh B
J Natl Cancer Inst; 2012 Jan; 104(1):12-3, 16-7. PubMed ID: 22173586
[No Abstract] [Full Text] [Related]
40. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
Roukos DH
Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
